The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Incidence rates and treatment of neuropathic pain conditions in the general population ☆
Abstract
Incidence rate estimates of neuropathic pain are scanty and mostly address single types whereas the scope of the disease is wide. We aimed to calculate the incidence rates of neuropathic pain conditions in the Dutch general population and to assess treatment strategies in primary care. The study population included persons registered for at least one year in the Integrated Primary Care Information (IPCI) database between 1996 and 2003. Neuropathic pain was ascertained and classified by systematic review of computerized longitudinal medical records. Incidence rates (IR) were calculated, and the treatment for pain was compared to age and gender matched controls. Among 362,693 persons contributing 1,116,215 person years (PY), we identified 9135 new cases of neuropathic pain (IR: 8.2/1000 PY, 95%CI: 8.0-8.4). Mononeuropathy and carpal tunnel syndrome were the most frequent types with 4.3 and 2.3 cases/1000 PY followed by diabetic peripheral neuropathy and post-herpetic neuralgia at 0.72 and 0.42/1000 PY. Neuropathic pain was 63% more common in women than in men and peaked between the ages 70 and 79. More than 50% of cases received pain medication within 6 months after diagnosis, mostly consisting of NSAIDs or aspirin. Anticonvulsants and tricyclic antidepressants were only used by 4.8 and 4.7% of cases. Neuropathic pain is a rather frequent condition with an annual incidence of almost 1% of the general population and affecting women and middle-aged persons more often. The treatment mostly consisted of regular analgesics suggesting that pharmacological treatment of neuropathic pain is suboptimal.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gabapentin for acute and chronic pain
Wiffen, P. J., McQuay, H. J., Edwards, J., & Moore, R. A. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005452.pub2 · Cited by 230
RetractedPrevalence of chronic pain with neuropathic characteristics in the general population
Bouhassira, D., Lantéri-Minet, M., Attal, N., Laurent, B., & Touboul, C. (2008) · Pain · doi:10.1016/j.pain.2007.08.013 · Cited by 1,745
Development and validation of the Neuropathic Pain Symptom Inventory
Bouhassira, D., Attal, N., Fermanian, J., Alchaar, H., Gautron, M., Masquelier, E., Rostaing, S., Lanteri-Minet, M., Collin, E., Grisart, J., et al. (2004) · Pain · doi:10.1016/j.pain.2003.12.024 · Cited by 1,329
Torrance, N., Smith, B. H., Bennett, M. I., & Lee, A. J. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.11.008 · Cited by 1,000
EFNS guidelines on pharmacological treatment of neuropathic pain
Attal, N., Cruccu, G., Haanpää, M., Hansson, P., Jensen, T. S., Nurmikko, T., Sampaio, C., Sindrup, S., & Wiffen, P. (2006) · European Journal of Neurology · doi:10.1111/j.1468-1331.2006.01511.x · Cited by 880
MacDonald, B. K. (2000) · Brain · doi:10.1093/brain/123.4.665 · Cited by 858 · cited 1×
“[19], who themselves judge theirs as an underestimation, but are in line with those reported for post-herpetic neuralgia, trigeminal neuralgia and phantom limb pain by Hall et al.”
ResultAntidepressants for neuropathic pain
Saarto, T., & Wiffen, P. J. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005454.pub2 · Cited by 764
Bennett, M. I., Smith, B. H., Torrance, N., & Potter, J. (2005) · The Journal of Pain · doi:10.1016/j.jpain.2004.11.007 · Cited by 695
Epidemiology of peripheral neuropathy.
Martyn, C. N., & Hughes, R. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.4.310 · Cited by 597
Carpal tunnel syndrome incidence in a general population
Mondelli, M., Giannini, F., & Giacchi, M. (2002) · Neurology · doi:10.1212/wnl.58.2.289 · Cited by 462
Research works printed but not linked: 3
- Nordstrom, 1998, Incidence of diagnosed carpal tunnel syndrome in a general population., Epidemiology, 9, 342, 10.1097/00001648-199805000-00021 · doi:10.1097/00001648-199805000-00021
- Rossignol, 1997, Carpal tunnel syndrome: what is attributable to work? The Montreal study., Occup Environ Med, 54, 519, 10.1136/oem.54.7.519 · doi:10.1136/oem.54.7.519
- Stevens, 1988, Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980., Neurology, 38, 134, 10.1212/WNL.38.1.134 · doi:10.1212/wnl.38.1.134
Cited by
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Costigan, M., Scholz, J., & Woolf, C. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135531 · Cited by 2,025
NeuPSIG guidelines on neuropathic pain assessment
Haanpää, M., Attal, N., Backonja, M., Baron, R., Bennett, M., Bouhassira, D., Cruccu, G., Hansson, P., Haythornthwaite, J. A., Iannetti, G. D., et al. (2011) · Pain · doi:10.1016/j.pain.2010.07.031 · Cited by 1,060
Neuropathic pain: mechanisms and their clinical implications
Cohen, S. P., & Mao, J. (2014) · BMJ · doi:10.1136/bmj.f7656 · Cited by 802
Palmer, S. C., Tendal, B., Mustafa, R. A., Vandvik, P. O., Li, S., Hao, Q., Tunnicliffe, D., Ruospo, M., Natale, P., Saglimbene, V., et al. (2021) · BMJ · doi:10.1136/bmj.m4573 · Cited by 679
“11 The results provide evidence to support guideline recommendations made in 2019 that patients at highest risk of cardiovascular disease and kidney disease are likely to have important benefits on risks of cardiovascular events and heart failure with SGLT-2 inhibitors.”
ResultIncidence of facial pain in the general population
Koopman, J. S. H. A., Dieleman, J. P., Huygen, F. J., de Mos, M., Martin, C. G. M., & Sturkenboom, M. C. J. M. (2009) · Pain · doi:10.1016/j.pain.2009.08.023 · Cited by 489
Self-citation
Metadata
- Authors
- Dieleman, J. P., Kerklaan, J., Huygen, F. J. P. M., Bouma, P. A. D., & Sturkenboom, M. C. J. M.
- Venue
- Pain
- Published
- 2008-07-31
- Volume
- 137
- Issue
- 3
- Pages
- 681-688
- ISSN
- 0304-3959 (ISSN-L)
- OpenAlex
- W2094162828
- Cited by
- 353
- References
- 29
- FWCI
- 12.67
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incidence rates and treatment of neuropathic pain conditions in the general population ☆. https://app.cochat.ai/papers/10.1016/j.pain.2008.03.002
- The paper
- Dieleman, J. P., Kerklaan, J., Huygen, F. J. P. M., Bouma, P. A. D., & Sturkenboom, M. C. J. M. (2008). Incidence rates and treatment of neuropathic pain conditions in the general population ☆. Pain. https://doi.org/10.1016/j.pain.2008.03.002
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
